TEST BANK For Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics, 8th Edition by Nader Rifai, Verified Chapters 1 - 49, Complete Newest Version

Test bank for Tietz Fundamentals of Clinical Chemistry and
fg fg fg fg fg fg fg fg




Molecular Diagnostics,
fg fg fg




8th Edition by Nader Rifai, PhD
fg fg fg fg fg fg




Chapters 1 - 49 fg fg fg fg

,Tietz Fundamentals of Clinical Chemistry and Molecular Diagnostics 8th Edition Test Bank
fg fg fg fg fg fg fg fg
fg
fg fg




Table of contents:
fg fg




I. Principles Of Laboratory Medicine
fg fg fg fg




Chapter 1. Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine
fg fg fg fg fg fg fg fg




Chapter 2. Selection and Analytical Evaluation of Methods — With Statistical Techniques
fg fg fg fg fg fg fg fg fg fg fg




Chapter 3. Clinical Evaluation of Methods
fg fg fg fg fg




Chapter 4. Evidence-Based Laboratory Medicine
fg fg fg fg




Chapter 5. Establishment and Use of Reference Values
fg fg fg fg fg fg fg




Chapter 6. Specimen Collection, Processing, and Other Preanalytical Variables
fg fg fg fg fg fg fg fg




Chapter 7. Quality Management
fg fg fg




II. Analytical Techniques And Instrumentation
fg fg fg fg




Chapter 8. Principles of Basic Techniques and Laboratory Safety
fg fg fg fg fg fg fg fg




Chapter 9. Optical Techniques
fg fg fg




Chapter 10. Electrochemistry and Chemical Sensors
fg fg fg fg fg




Chapter 11. Electrophoresis
fg fg




Chapter 12. Chromatography
fg fg




Chapter 13. Mass Spectrometry
fg fg fg




Chapter 14. Enzyme and Rate Analyses
fg fg fg fg fg




Chapter 15. Immunochemical Techniques
fg fg fg




Chapter 16 Automation fg fg




Chapter 17. Point-of-Care Instrumentation
fg fg fg




III. Analytes
f g




Chapter 18. Amino Acids, Peptides, and Proteins
fg fg fg fg fg fg




Chapter 19. Serum Enzymes
fg fg fg




Chapter 20. Tumor Markers and Cancer Genes
fg fg fg fg fg fg




Chapter 21. Kidney Function Tests — Creatinine, GFR, Urea, and Uric Acid
fg fg fg fg fg fg fg fg fg fg fg




Chapter 22. Carbohydrates
fg fg




Chapter 23. Lipids, Lipoproteins, Apolipoproteins, and Other Cardiac Risk Factors
fg fg fg fg fg fg fg fg fg




Chapter 24. Electrolytes and Blood Gases
fg fg fg fg fg




Chapter 25. Hormones fg fg




Chapter 26. Catecholamines and Serotonin
fg f g fg fg




Chapter 27. Vitamins, Trace Elements, Nutritional Assessment
fg f g fg fg fg fg




Chapter 28. Hemoglobin, Iron, and Bilirubin
fg fg fg fg fg




Chapter 29. Porphyrins and Porphyrias
fg fg fg fg




Chapter 30. Therapeutic Drugs and Their Management
fg fg fg fg fg fg




Chapter 31. Clinical Toxicology
fg fg fg




Chapter 32. Toxic Metals
fg f g fg




IV. Pathophysiology
f g




Chapter 33. Diabetes fg fg

,Chapter 34. Cardiovascular Disease
fg f g fg




Chapter 35. Kidney Disease
fg fg fg




Chapter 36. Physiology and Disorders of Water, Electrolyte, and Acid-Base Metabolism
fg f g fg fg fg fg fg fg fg fg




Chapter 37. Liver Disease
fg fg fg fg




Chapter 38. Gastrointestinal and Pancreatic Diseases
fg f g fg fg fg




Chapter 39. Disorders of Bone and Mineral Metabolism
fg fg fg fg fg fg fg fg




Chapter 40. Disorders of the Pituitary Gland
fg fg fg fg fg fg fg




Chapter 41. Disorders of the Adrenal Cortex
fg f g fg fg fg fg




Chapter 42. Thyroid Disorders
fg f g fg




Chapter 43. Reproduction-Related Disorders
fg f g fg




Chapter 44. Pregnancy and Prenatal Testing
fg fg fg fg fg fg




Chapter 45. Newborn Screening and Inborn Errors of Metabolism
fg f g fg fg fg fg fg fg




Chapter 46. Pharmacogenetics
fg fg




V. Molecular Diagnostics
f g fg




Chapter 47. Principles of Molecular Biology
fg fg fg fg fg




Chapter 48. Nucleic Acid Techniques and Applications
fg fg fg fg fg fg




Chapter 49. Genomes and Nucleic Acid Alterations
fg fg fg fg fg fg

, Chapter 01: Clinical Chemistry, Molecular Diagnostics, and Laboratory Medicine
fg fg fg fg fg fg fg fg



TestBank
fg fg




MULTIPLE CHOICE fg




1. An individual working in a clinical chemistry laboratory is married to a sales representative
fg fg fg fg fg fg fg fg fg fg fg fg fg



who works for a company that sells chemistry laboratory supplies. When the laboratory
fg fg fg fg fg fg fg fg fg fg fg fg fg



manager requests a list of needed supplies, cost of supplies, and vendors, this individual
fg fg fg fg fg fg fg fg fg fg fg fg fg fg



onlyrecommends the spouse’s company as the vendor. This is considered to be a(n):
fg fg fg fg fg fg fg fg fg fg fg fg fg fg



a. accounting issue. fg



b. possible conflict of interest. fg fg fg



c. maintenance of confidentiality issue. fg fg fg



d. problem with resource allocation. fg fg fg




ANS: B fg



Concern has been raised over the interrelationships between practitioners in the medical
fg fg fg fg fg fg fg fg fg fg fg



fieldand commercial suppliers of drugs, devices, equipment, etc., to the medical profession.
fg fg fg fg fg fg fg fg fg fg fg fg fg



Similarly, relationships have been scrutinized between clinical laboratorians and
fg fg fg fg fg fg fg fg



manufacturers and providers of diagnostic equipment and supplies. These concerns led the
fg fg fg fg fg fg fg fg fg fg fg fg



National Institutes of Health (NIH) in 1995 to require official institutional review of
fg fg fg fg fg fg fg fg fg fg fg fg fg



financial disclosure by researchers and management of situations in which disclosure
fg fg fg fg fg fg fg fg fg fg fg



indicates potentialconflicts of interest.
fg fg fg fg fg




DIF: 1 REF: Page 4-5 fg fg fg fg OBJ: 6 | 7 fg fg fg




2. A patient visits her physician stating that her prescribed painkiller is not working to reduce
fg fg fg fg fg fg fg fg fg fg fg fg fg fg



the pain following her recent surgery. A friend of the patient claims that the same
fg fg fg fg fg fg fg fg fg fg fg fg fg fg fg



painkiller―worked wonders‖ to reduce her pain after the same surgery. The physician
fg fg fg fg fg fg fg fg fg fg fg fg fg



states that the difference in the effect of the drug might be caused by , which is studied
fg fg fg fg fg fg fg fg fg fg fg fg fg fg fg fg fg



in pharmacogenetics.
fg fg



a. epidemiology
b. an inherited disease fg fg



c. a conflict of interestfg fg fg



d. a genetic variation in drug-metabolizing enzymes
fg fg fg fg fg




ANS: D fg



Pharmacogenetics is the study of the genetic variation of drug metabolism fg fg fg fg fg fg fg fg fg fg



betweenindividuals.
fg fg




DIF: 1 REF: Page 3 fg fg f g fg OBJ: 1 fg




3. John works in a molecular diagnostics laboratory and receives a blood sample that has the
fg fg fg fg fg fg fg fg fg fg fg fg fg fg



name of a close friend printed on the bar-coded label. The genetic test that is ordered on
fg fg fg fg fg fg fg fg fg fg fg fg fg fg fg fg fg



thefriend’s sample would provide diagnostic information about a disorder that has a poor
fg fg fg fg fg fg fg fg fg fg fg fg fg fg



prognosis, and the test is usually performed by John. He asks a fellow employee to
fg fg fg fg fg fg fg fg fg fg fg fg fg fg fg



analyzethe sample for him and not divulge the results. This ethical issue concerns:
fg fg fg fg fg fg fg fg fg fg fg fg fg fg



a. confidentiality of patient genetic and medical information. fg fg fg fg fg fg



b. a conflict of interest.
fg fg fg



c. resource allocation. fg



d. diagnostic accuracy. fg